Simvastatin and Ezetimibe in Addition to Nonpharmacological Risk Factor Modification for Achieving New Low-Density Lipoprotein Cholesterol Targets

1 July 2008

journal article
research article
Published by Springer Nature in Herz

Vol. 33 (5) , 362-367
https://doi.org/10.1007/s00059-008-3084-6

Abstract

Though guidelines emphasize low-density lipoprotein cholesterol (LDL-C) lowering as an essential strategy for cardiovascular risk reduction, achieving target levels may be difficult.

Keywords

RISK FACTORS
ADVERSE EVENT

This publication has 0 references indexed in Scilit: